PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Detail   |   Print    Next page > 
     
Haleon and Singapore's Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women's Metabolic Health in Asia
2026-08-11T    Health Care/Hospital   Medical/Pharmaceuticals 
Global Study Results Published in Aesthetic Surgery Journal Open Forum Show Link Between Self-Confidence and Aesthetics
2026-08-11T    Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics   Medical/Pharmaceuticals 
Aureka Biotechnologies Raises US$100 Million Series B to Build a Biological World Model for Drug Discovery
2026-08-11T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lifespan Vision Ventures Leads Remedium Bio's Series A Financing
2026-08-10T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Unveiling a Smarter Future for Dentistry at China Dental Show 2026
2026-08-10T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine
2026-08-10T    Computer/Electronics   Consumer Electronics   Health Care/Hospital   Medical Equipment 
Ascletis Announces Initiation of Two Phase I Studies in U.S. for the Treatment of Obesity: ASC36 Once-Monthly Injection, an Amylin Receptor Peptide Agonist, and ASC36_35FDC Once-Monthly Injection, a Co-Formulation of ASC36 and GLP-1R/GIPR Peptide Agonist ASC35
2026-08-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Dx&Vx Signs Two Material Transfer Agreements in Latin America Within Two Months -- "Technology Validated Across Both Public and Private Sectors"
2026-08-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
New ReSound Sensiaâ„¢ hearing aids lift the voice you want to hear - not just the loudest
2026-08-10T    Consumer Electronics   Electronic Components   Health Care/Hospital   Medical Equipment 
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer
2026-08-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.